Kala Pharmaceuticals, Inc. announced that Charles McDermott notified company of his decision to resign as President and Chief Business Officer of the Company, effective August 7, 2017. Mr. McDermott's resignation is not due to any disagreement with the Company on any matter relating to the company's operations, policies or practices. In connection with Mr. McDermott's resignation, the Board appointed Mark Iwicki (age 50), the Company's Chief Executive Officer and Chairman of the Company's Board of Directors (the Board), as President, effective August 7, 2017. In addition to serving as President, Mr. Iwicki will continue to serve as the Company's Chief Executive Officer and Chairman of the Board, positions he has held since September 2015. Previously, Mr. Iwicki served as Executive Chairman of the Board from April 2015 to September 2015.